Verity Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Verity Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$377K	Sell	766 -129	-14%	-$70K	0.16%	154
2025 Q4	$519K	Sell	895 -701	-44%	-$396K	0.22%	127
2025 Q3	$774K	Buy	+1,596	New	+$743K	0.25%	97
2025 Q2	–	Sell	-1,040	Closed	-$518K	–	214
2025 Q1	$518K	Buy	1,040 +552	+113%	+$299K	0.21%	109
2024 Q4	$252K	Buy	488 +30	+7%	+$16.5K	0.14%	152
2024 Q3	$283K	Buy	+458	New	+$271K	0.11%	164
2023 Q2	–	Sell	-820	Closed	-$473K	–	189
2023 Q1	$473K	Buy	820 +373	+83%	+$210K	0.28%	95
2022 Q4	$246K	Buy	447 +20	+5%	+$10.6K	0.21%	138
2022 Q3	$217K	Buy	+427	New	+$239K	0.22%	153
2021 Q4	–	Sell	-422	Closed	-$241K	–	216
2021 Q3	$241K	Buy	+422	New	+$232K	0.16%	158

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Verity Asset Management's TMO Position: Q1 2026 in Review

Verity Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q1 2026, selling an estimated $70K and leaving 766 shares worth $377K. The position accounts for 0.16% of the portfolio, ranked #154.

Verity Asset Management first reported a position in TMO in Q3 2021 and has held it in 10 quarters since. The position peaked at $774K in Q3 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Verity Asset Management held 766 shares of Thermo Fisher Scientific worth $377K as of Q1 2026.
Verity Asset Management sold 129 Thermo Fisher Scientific shares in Q1 2026, an estimated $70K.
Thermo Fisher Scientific made up 0.16% of Verity Asset Management's portfolio in Q1 2026, its #154 holding.
Verity Asset Management first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 10 quarters since.
Verity Asset Management's Thermo Fisher Scientific position peaked at $774K in Q3 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Verity Asset Management's 13F filing for Q1 2026, filed 21 Apr 2026.